|
HS Code |
546908 |
| Name | Piperazine-1-Sulfonic Acid Dimethylamide |
| Chemical Formula | C6H15N3O2S |
| Molecular Weight | 193.27 g/mol |
| Cas Number | 138357-67-8 |
| Appearance | White to off-white solid |
| Solubility | Soluble in water |
| Purity | Typically ≥ 98% (as per supplier data) |
| Storage Conditions | Store at room temperature, keep container tightly closed |
| Synonyms | N,N-dimethylpiperazine-1-sulfonamide |
| Smiles | CN(C)S(=O)(=O)N1CCNCC1 |
| Inchi | InChI=1S/C6H15N3O2S/c1-9(2)12(10,11)8-5-3-7-4-6-8/h3-7H2,1-2H3 |
| Application | Used as an intermediate in organic synthesis |
As an accredited Piperazine-1-Sulfonic Acid Dimethylamide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Piperazine-1-Sulfonic Acid Dimethylamide, 25g, is packaged in a sealed amber glass bottle with a secure screw cap for protection. |
| Shipping | **Shipping Description:** Piperazine-1-Sulfonic Acid Dimethylamide is shipped as a stable solid in tightly sealed containers to prevent moisture uptake and contamination. It should be transported in compliance with chemical safety regulations, kept dry, and protected from extreme temperatures. Handle with care, using appropriate protective equipment during transport and handling. |
| Storage | Piperazine-1-Sulfonic Acid Dimethylamide should be stored in a tightly sealed container at room temperature, in a cool, dry, and well-ventilated area. Keep it away from heat, moisture, and incompatible substances such as strong oxidizers. Ensure the storage area is equipped for handling chemicals, with proper labeling and restricted access to authorized personnel only. Avoid exposure to direct sunlight. |
Applications of Piperazine-1-Sulfonic Acid Dimethylamide in Industrial ManufacturingPiperazine-1-Sulfonic Acid Dimethylamide supports advanced chemical synthesis in a variety of specialized industrial segments. As a direct manufacturer, we align our formulation, quality, and regulatory processes with the strict requirements of each downstream application to ensure stable quality, precise functionality, and consistent supply for industry customers worldwide. 1. Pharmaceutical Intermediate for Sulfonamide Drug SynthesisMajor pharmaceutical companies use this sulfonic acid derivative as a structural intermediate in producing sulfonamide antibiotics and other specialty drugs. Its reactivity and purity profile enable precise sulfonation and amidation steps during API synthesis, supporting controlled molecular modification required for regulated drug markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Ion Exchange Resin Functionalization AgentThis chemical serves as a key functionalizing agent for introducing sulfonamide-linked groups into polymer backbones during ion exchange resin production. Its specific reactivity provides high site-selectivity, enabling resin manufacturers to achieve custom binding profiles, ion selectivity ranges, and thermal stability for downstream use in water purification. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Electroplating Additive for Nickel and Alloy BathsElectroplating formulators integrate this compound as a bath stabilizer or grain refiner in advanced nickel or nickel alloy procedures. Owing to its polar structure and control over metal ion mobility, it adjusts coating morphology and improves uniformity on complex substrates. This supports consistent finish in automated and high-throughput metal coating lines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fine Chemical Synthesis and Specialty Polymer ModifiersChemical manufacturers employ this material as a building block for producing specialized sulfonamide-based fine chemicals and as a chain modifier in the synthesis of high-performance specialty polymers. Its predictable reactivity with active halides and anhydrides supports the production of molecularly-tailored chemicals serving electronics, coatings, and advanced materials markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Analytical Reagent for Medical and Environmental Testing LabsSpecialty laboratories source this chemical as a calibration and derivatization reagent for HPLC and LC-MS analysis of sulfonamide-containing compounds. The compound’s structure offers reliable response and interaction in quantitative assays for pharmaceuticals, food residue, and environmental contaminant monitoring. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Piperazine-1-Sulfonic Acid Dimethylamide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Many years on the production floor, handling batches of Piperazine-1-sulfonic acid dimethylamide, reveal what simple chemical listings don’t share. This compound, which some researchers recognize under the alternative code PSADMA or by its chemical formula C6H15N3O2S, often gets tucked away behind catalog numbers. We work with it in large volumes for the pharmaceutical sector, battery innovators, and specialty polymer developers who look for a very specific set of performance criteria they cannot get elsewhere. Most think of piperazine chemistry as niche; to us, it’s practically routine—a backbone for new ideas in high-purity synthesis.
Producing Piperazine-1-sulfonic acid dimethylamide brings a unique set of challenges. The synthesis calls for highly-controlled reaction environments—strictly water-free, oxygen-free, with active temperature monitoring. If you cut corners here, trace contaminants creep in, and downstream applications quickly show the defects. Downstream users, particularly process chemists, trust us to supply material that consistently hits narrow margins for purity (usually over 99%), moisture content, and trace metals. Achieving this purity does not only depend on starting quality; filtration, controlled crystallization, and dedicated storage all matter. Day in, day out, we focus on reproducibility, not only on numbers from a specification sheet but from parallel HPLC and GC-MS results batch after batch. That’s the kind of reliability that product developers—especially those working with tight regulatory filings or sensitive analytical tests—expect from direct manufacturers.
As someone who has seen requests from gram scale all the way to multi-ton orders, a few points stick out about Piperazine-1-sulfonic acid dimethylamide’s chemistry. It flows as a white to off-white crystalline powder that resists water, stays stable up to moderate temperatures, and doesn’t quickly absorb atmospheric moisture. Our principal grade runs to a minimum assay of 99%, with sulfate, chloride, and trace amines below method-detectable limits. Melting point hovers around 170°C, verified on every incoming batch of starting material as well as outgoing lots. Particle size is controlled—not out of habit, but to avoid downstream filtration headaches in those making injectable drug actives, proton-conducive membranes for battery research, or electronic chemical makers who rely on dust-free supply. Because we run our own lines, every adjustment in drying, grinding, or packaging gets logged and checked in our internal audits.
Those designing modern pharmaceutical intermediates choose Piperazine-1-sulfonic acid dimethylamide if they want the unique balance between a mild base and a sulfonic acid group that won’t decompose under gentle heating. Peptide bond formation, for instance, takes advantage of both the nucleophilic amine (not as aggressive as free piperazine) and the sulfonyl group’s electronic stabilization. Battery labs run trials with this molecule as a stable cationic dopant, aiming for increased solubility in polar aprotic solvents—here, batch reproducibility means fewer wasted cell prototypes. Polymer chemists, especially in membrane technology, seek functional groups stable during cross-linking under acidic or basic conditions. In these settings, purity and particulate control matter more than the metric tons available off the shelf. Early on, we learned that when our QC team noticed minor particle aggregation, it showed up as filter blockages or inconsistent functionalization rates in the field—a lesson that changed our final sieving processes.
From a producer’s view, Piperazine-1-sulfonic acid dimethylamide stands well apart from the many simple piperazine salts or unsubstituted analogs. The inclusion of both the sulfonic acid and dimethylamide groups confers a unique chemical behavior; the compound remains neutral at physiological pH, doesn’t scavenge ambient carbon dioxide as vigorously as primary or secondary amines, and resists hydrolysis in air. We’ve run stability studies against standard piperazine hydrochloride, mesylates, and related quaternary ammonium salts—here, PSADMA shows longer shelf life and reduced discoloration under warehouse conditions. Clients in the pharmaceutical sector often cross-compare it with HEPES or PIPES buffering agents but return to PSADMA when working with systems sensitive to alkali metals or when low-UV background is critical, especially during peptide synthesis or capillary electrophoresis. In energy applications, its low metal content and lack of peroxide-forming functional groups win favor over many older cationic additives, which often introduce trace iron or sodium in the manufacturing process.
Too often, purchasers focus on technical data alone. From experience, tight quality controls translate directly to fewer process disruptions, higher yields in synthesis, and end products with improved stability. Take pharmaceutical manufacturers as an example—they submit our batch COA alongside regulatory filings, count on the absence of genotoxic impurities, and rely on us for long-term supply consistency. We answer questions about the manufacturing route, not only the final purity: Did we use chlorinated solvents at any stage? Are heavy metal levels charted per USP and ICH guidelines every quarter? Was final packaging handled in a filtered-air unit? These questions cannot be faked or answered by simple intermediaries; only those directly overseeing daily production cycles possess the records and insight.
Over the years, we’ve built a habit of checking in with customer labs, not only when things go off-spec but during routine production. Researchers and production chemists share their handling tips: some dissolve our product directly in DMF or DMSO, others blend it with organic bases for coupling chemistry. We hear if they’ve cleared up cloudiness using a brief vacuum drying or needed to sieve out fines for microfluidic channels. It’s not just the purity but also physical consistency that gets remarks. Lab trials show our product maintains its structure in high-humidity rooms, outlasting typical sulfonic acid analogs that tend to clump. Such real-use observations guide minor adjustments on our side, such as optimizing drying schedules or upgrading tamper-proof packaging, all based on what buyers actually experience, not what a generic specification recommends.
Running a chemical manufacturing operation demands attention to downstream environmental impact. Piperazine-1-sulfonic acid dimethylamide synthesis creates minimal hazardous by-products if operated tightly; effluent scrubbing and closed reactions avoid atmospheric sulfur emissions. Our plant recycles nearly all spent solvents and any wash-down water gets treated to remove trace amines or sulfones before discharge. Annual hazard analyses, conducted with local regulatory bodies, show that this specific product’s life-cycle risk is lower than for many halogenated or strongly basic alternatives. Bulk buyers—including those in regulated sectors such as medical device manufacturing—frequently ask for documentation confirming absence of Persistent Organic Pollutants (POPs) or evidence of compliance with the latest environmental standards. Since we run synthesis internally, we maintain transparent records and adapt technology upgrades much faster than purchasers might expect from a contract-only operation. We’ve even implemented real-time air monitoring to catch fugitive emissions at the earliest stage, rather than relying on scheduled checks. These steps stem from facing real compliance audits and engaging openly with inspectors.
Customers used to working with traders or large distribution networks might assume lead times fluctuate with global logistics. Manufacturing piperazine-1-sulfonic acid dimethylamide in-house, from raw feedstock down to packaged powder, lets us align production batches directly with end-user demand forecasts. We keep strategic reserves of purification reagents and packaging supplies to manage unexpected spikes in demand, especially at the start of the academic year or during regulatory changes in the pharmaceutical supply base. Requests for tailored packaging formats—high-barrier laminate, glass, or certified-polymer drums—get routed directly to our shipping floor without third-party delays. We often fill highly-specific orders: small packs for R&D, multi-ton bulk for production, and everything in between. By talking with customers during their validation runs, we can tweak granularity or packing densities so that downstream operations run smoother. The point is not simply to deliver more tons but to help users achieve consistent process results with fewer headaches and less unpredictability.
Scaling production of Piperazine-1-sulfonic acid dimethylamide from lab to plant forces us to think beyond basic yields. Physical properties shift subtly at higher volumes; what pours like crystalline sugar in a flask can behave more like wet sand in a reactor bin. Plant-scale reactors need agitation rates adjusted to prevent local hot spots that promote side reactions. We invest time in pilot batches, analyzing every spectrum and monitoring impurity drift. Early failures revealed that a minor amount of dimethylformamide left after dehydration leads to off-spec amine byproducts—and that small deviation, undetectable in old stockroom checks, triggers regulatory queries from high-stakes customers. Government agencies expect tracking from lot to lot, validated methods for residual solvents, and documentation showing equipment cleaning between campaign runs. Only a manufacturer with actual control over their reactors, storage silos, and cleaning regimens can answer these with more than reassurances.
Problems don’t announce themselves in spreadsheets; they show up in subtle changes—slower filtration, faint yellowing, or whiffs of ammonia in the drum. One lot might show slightly higher chloride, tracked back to an inconsistent water deionizer upstream. Discovery means reacting fast, not blaming suppliers or hiding behind paperwork. Technicians and chemists with years in the same plant notice when a batch feels different during drying or flows oddly during packaging. These “soft signals” often catch drift before QC results flag a problem. Our role includes communicating unusual findings proactively to customers—as soon as any anomaly appears in a trend line, not only when a formal non-conformance occurs. Years of closed-loop feedback create a working trust that traders cannot supply; buyers trust a response rooted in hands-on familiarity, not armchair analysis.
Within any specialty chemical supply, continuity matters as much as innovation. Developers iterating new battery chemistries, pharmaceutical agents, or water-treatment membranes want a future-proofed partner who’ll answer technical queries years after the first order ships. Our ongoing investment in both process automation and skilled personnel ensures improvements land where users notice them—reduced batch-to-batch color drift, higher moisture stability in sealed units, or cleaner bulk containers for direct transfer. Conversation with engineers and chemists, not only procurement officers, shapes our roadmap. Their need for secure tolerances, long-term regulatory compliance, and immediate troubleshooting steers many internal improvements—whether faster lot release times, more robust leak barriers in drum liners, or earlier notification of supply chain turbulence. We treat these as part of everyday operations, not a premium add-on, because our reputation depends on outcomes rather than surface promises.
As digital traceability tightens across chemical sectors, manufacturing Piperazine-1-sulfonic acid dimethylamide now involves more than classic batch records. Networked sensors in our plant track every variable—reactant feed rates, temperatures, even batch-to-batch shifts in raw material isotopic ratios. Blockchain-backed supply verification, demanded increasingly by multinational buyers, rests easier when the product never leaves our custody before shipping to customers. For clients dealing with regulatory transparency—unique device identifiers, anti-counterfeiting regulations—direct manufacturing gives answers at the scan of a QR code. Over time, the field will see fewer generic intermediaries and more direct producer relationships, with data flowing both ways. As manufacturing evolves, the difference will only sharpen between those who can vouch for every gram made and generic brands hoping batch records suffice.
No operator claims perfection, but dedicated improvement cycles spin every year within our plant. Customer input and post-market surveillance work hand in hand with process automation. We find that as critical applications become ever more demanding, incremental advances in filtration, drying, and analytics drive real-world advantages. Our chromatography protocols update alongside pharmacopoeia changes; our trace metals screening leverages inductively coupled plasma mass spectrometry for more sensitive detection. Developing new derivatives or packaging adaptations, we test outcomes in real handling—not only theoretical conditions. In difficult export situations, our in-house compliance team clears up every regulatory request, avoiding shipment delays or impoundments caused by ambiguous grades or missing paperwork. Each of these improvements comes directly from hands-on challenges and feedback within the specialty chemical production context, outside the templated playbooks of resellers or distribution houses.
Piperazine-1-sulfonic acid dimethylamide might seem to many as one more specialty compound among a thousand, but direct experience in making, testing, packaging, and following up across industries makes clear how vital its details are. Sourcing it through direct manufacturing means not just meeting a chemical specification, but working with a collaborative team that recognizes subtle differences batch to batch, supports every technical query, and has the on-the-ground perspective on yield, contamination risks, and end-use troubleshooting. For any developer committed to reproducibility, quality, and regulatory traceability, the choice to engage with direct producers remains foundational—ensuring both immediate problem solving and a secure path forward as science and technology move on.